Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;192(3):e66-e69.
doi: 10.1111/bjh.17237. Epub 2020 Nov 20.

Sex differences in outcomes in multiple myeloma

Benjamin A Derman  1 , Spencer S Langerman  2 , Maya Maric  2 , Andrzej Jakubowiak  1 , Wei Zhang  3 , Brian C-H Chiu  2
Affiliations

Sex differences in outcomes in multiple myeloma

Benjamin A Derman et al. Br J Haematol. 2021 Feb.
No abstract available

Keywords: gender; multiple myeloma; sex.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

BAD, SL, MM, WZ and BCC declare no competing financial interests. AJJ declares: Honoraria — Amgen, Bristol Myers Squibb, Celgene, GlaxoSmithKline; Abbvie, Janssen, Karyopharm Therapeutics, Millennium, Sanofi, Skyline Diagnostics, Takeda; Consulting or Advisory Role — Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, AbbVie, Janssen, Karyopharm Therapeutics, Millennium, Sanofi, Skyline Diagnostics, Takeda.

Figures

Fig 1.
Fig 1.
Kaplan–Meier survival curves for MM by sex. (A) Overall survival of SEER patients. (B) Overall survival of MMRF patients. (C) Progression-free survival of MMRF patients. SEER: National Cancer Institute’s Surveillance, Epidemiology, and End Results program. MMRF: Multiple Myeloma Research Foundation (MMRF) CoMMpass study.
See this image and copyright information in PMC

References

    1. Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF. Sex disparities in cancer mortality and survival. Cancer Epidemiol Prev Biomark. 2011;20:1629–37. - PMC - PubMed
    1. Boyd KD, Ross FM, Chiecchio L, Dagrada G, Konn ZJ, Tapper WJ, et al. Gender disparities in the tumor genetics and clinical outcome of multiple myeloma. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2011;20:1703–7. - PMC - PubMed
    1. Bird SA, Cairns D, Davies FE, Boyd K, Cook G, Drayson MT, et al. Sex Differences in Multiple Myeloma Biology and Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial. Blood. 2019. November 13;134(Supplement_1):4374. - PMC - PubMed
    1. Thompson AE, Anisimowicz Y, Miedema B, Hogg W, Wodchis WP, Aubrey-Bassler K. The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study. BMC Fam Pract [Internet]. 2016. March 31 [cited 2020 Sep 7];17. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815064/. - PMC - PubMed
    1. Jäger U, Fridrik M, Zeitlinger M, Heintel D, Hopfinger G, Burgstaller S, et al. Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response. Haematologica. 2012;97:1431–8. - PMC - PubMed

Publication types